Tiziana Life Sciences PLC Gains 22.4%

Tiziana Life Sciences PLC (TLSA:NASDAQ) rocketted at $1.07, a gain of 22.4%. On Tue, Mar 28, 2023, TLSA:NASDAQ touched a New 2-Week High of $1.07. The stock appeared on our News Catalysts scanner on Tue, Mar 28, 2023 at 07:16 AM in the 'BIOTECH' category. From Tue, Mar 14, 2023, the stock recorded 70.00% Up Days and 54.55% Green Days

About Tiziana Life Sciences PLC (TLSA:NASDAQ)

Tiziana Life Sciences PLC is involved in the business of developing novel therapeutics for cancer with a focus on late-stage growth and complementary diagnostic tools, with the capability of predicting disease aggressiveness and prognosis in breast cancer patients. The group also has interests, beyond pure oncology, in the discovery and development of monoclonal antibody-based biologics used to benefit patients with inflammatory and auto-immune disorders. The company has a single reporting segment, The Research, and Development of Biotechnological and Pharmaceutical Products. Its lead compound, milciclib (TZLS-201), is a molecule which blocks the action of specific enzymes involved in cell division as well as a number of other protein kinases.